GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » FCF Yield %

Cinclus Pharma Holding AB (OSTO:CINPHA) FCF Yield % : -36.85 (As of Apr. 26, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Cinclus Pharma Holding AB's Trailing 12-Month Free Cash Flow is kr-178.37 Mil, and Market Cap is kr483.99 Mil. Therefore, Cinclus Pharma Holding AB's FCF Yield % for today is -36.85%.

The historical rank and industry rank for Cinclus Pharma Holding AB's FCF Yield % or its related term are showing as below:

OSTO:CINPHA' s FCF Yield % Range Over the Past 10 Years
Min: -37.63   Med: -19.38   Max: -13.38
Current: -36.85


During the past 4 years, the highest FCF Yield % of Cinclus Pharma Holding AB was -13.38%. The lowest was -37.63%. And the median was -19.38%.

OSTO:CINPHA's FCF Yield % is ranked worse than
92.23% of 1017 companies
in the Drug Manufacturers industry
Industry Median: 0.05 vs OSTO:CINPHA: -36.85

Cinclus Pharma Holding AB's FCF Margin % for the quarter that ended in Dec. 2024 was -1,715.81%.


Cinclus Pharma Holding AB FCF Yield % Historical Data

The historical data trend for Cinclus Pharma Holding AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB FCF Yield % Chart

Cinclus Pharma Holding AB Annual Data
Trend Dec21 Dec22 Dec23 Dec24
FCF Yield %
- - - -17.93

Cinclus Pharma Holding AB Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -6.08 -12.99 -31.59

Competitive Comparison of Cinclus Pharma Holding AB's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Cinclus Pharma Holding AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cinclus Pharma Holding AB's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cinclus Pharma Holding AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Cinclus Pharma Holding AB's FCF Yield % falls into.


;
;

Cinclus Pharma Holding AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Cinclus Pharma Holding AB's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-178.367 / 994.98244
=-17.93%

Cinclus Pharma Holding AB's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-78.584 * 4 / 994.98244
=-31.59%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cinclus Pharma Holding AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Cinclus Pharma Holding AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Cinclus Pharma Holding AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cinclus Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kungsbron 1, Stockholm, SWE, SE-111 22
Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines